Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment
Background: Limited data are available on other substance use in e-cigarettes (OSUE). The aim of this research was to determine the prevalence and predictors of OSUE among a sample of individuals in substance use disorder (SUD) treatment. Methods: In 2019, we surveyed 553 individuals from 18 residen...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Addictive Behaviors Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352853222000608 |
| _version_ | 1811295239129792512 |
|---|---|
| author | Carmen L. Masson Noah R. Gubner Neal Benowitz Sindhushree Hosakote Thao Le Joseph R. Guydish |
| author_facet | Carmen L. Masson Noah R. Gubner Neal Benowitz Sindhushree Hosakote Thao Le Joseph R. Guydish |
| author_sort | Carmen L. Masson |
| collection | DOAJ |
| description | Background: Limited data are available on other substance use in e-cigarettes (OSUE). The aim of this research was to determine the prevalence and predictors of OSUE among a sample of individuals in substance use disorder (SUD) treatment. Methods: In 2019, we surveyed 553 individuals from 18 residential SUD treatment programs in California, USA. Individuals reporting any lifetime use of an e-cigarette containing nicotine (n = 279) were asked about ever use of drugs other than nicotine in their e-cigarette. Those who reported use of non-nicotine drugs in their e-cigarette also reported what psychoactive drugs were used. Results: Among all the participants, 25 % (n = 139) . reported ever engaging in OSUE. The most common drugs used in vaping devices were marijuana/THC/hash, (70.5 %, n = 98) and amphetamines/methamphetamine (51.1 %, n = 71). Among those who had engaged in OSUE, 44.6 % (n = 62) had vaped drugs for which they sought treatment. Older persons (OR = 0.93, CI 0.91, 0.95) and African Americans (OR = 0.48, CI 0.24, 0.94) were less likely to have ever engaged in OSUE, while persons in treatment for opioid use were more likely (OR = 1.71, CI 1.08, 2.71). Conclusion: Among a sample of clients in SUD treatment, about 25% had ever engaged in OSUE, with THC/marijuana and amphetamines most commonly reported. Further research is needed to evaluate the OSUE to understand the reasons for use and implications among persons enrolled in SUD treatment. |
| first_indexed | 2024-04-13T05:29:40Z |
| format | Article |
| id | doaj.art-9ecc478c31dc483ba00868229d57ad50 |
| institution | Directory Open Access Journal |
| issn | 2352-8532 |
| language | English |
| last_indexed | 2024-04-13T05:29:40Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Addictive Behaviors Reports |
| spelling | doaj.art-9ecc478c31dc483ba00868229d57ad502022-12-22T03:00:29ZengElsevierAddictive Behaviors Reports2352-85322022-12-0116100465Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatmentCarmen L. Masson0Noah R. Gubner1Neal Benowitz2Sindhushree Hosakote3Thao Le4Joseph R. Guydish5Department of Psychiatry and Behavioral Sciences, University of California San Francisco, CA, USA; Corresponding author at: University of California San Francisco, Department of Psychiatry and Behavioral Sciences, USA.University of Washington, Department of Psychiatry and Behavioral Sciences, Evidence Based Practice Institute, Seattle, WA, USADepartment of Medicine, University of California, San Francisco, CA, USAPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, CA, USAPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, CA, USADepartment of Psychiatry and Behavioral Sciences, University of California San Francisco, CA, USA; Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, CA, USABackground: Limited data are available on other substance use in e-cigarettes (OSUE). The aim of this research was to determine the prevalence and predictors of OSUE among a sample of individuals in substance use disorder (SUD) treatment. Methods: In 2019, we surveyed 553 individuals from 18 residential SUD treatment programs in California, USA. Individuals reporting any lifetime use of an e-cigarette containing nicotine (n = 279) were asked about ever use of drugs other than nicotine in their e-cigarette. Those who reported use of non-nicotine drugs in their e-cigarette also reported what psychoactive drugs were used. Results: Among all the participants, 25 % (n = 139) . reported ever engaging in OSUE. The most common drugs used in vaping devices were marijuana/THC/hash, (70.5 %, n = 98) and amphetamines/methamphetamine (51.1 %, n = 71). Among those who had engaged in OSUE, 44.6 % (n = 62) had vaped drugs for which they sought treatment. Older persons (OR = 0.93, CI 0.91, 0.95) and African Americans (OR = 0.48, CI 0.24, 0.94) were less likely to have ever engaged in OSUE, while persons in treatment for opioid use were more likely (OR = 1.71, CI 1.08, 2.71). Conclusion: Among a sample of clients in SUD treatment, about 25% had ever engaged in OSUE, with THC/marijuana and amphetamines most commonly reported. Further research is needed to evaluate the OSUE to understand the reasons for use and implications among persons enrolled in SUD treatment.http://www.sciencedirect.com/science/article/pii/S2352853222000608VapingE-cigarettesDrug useElectronic nicotine delivery systemElectronic cigarettesSubstance use disorder treatment |
| spellingShingle | Carmen L. Masson Noah R. Gubner Neal Benowitz Sindhushree Hosakote Thao Le Joseph R. Guydish Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment Addictive Behaviors Reports Vaping E-cigarettes Drug use Electronic nicotine delivery system Electronic cigarettes Substance use disorder treatment |
| title | Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| title_full | Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| title_fullStr | Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| title_full_unstemmed | Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| title_short | Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| title_sort | lifetime use of non nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment |
| topic | Vaping E-cigarettes Drug use Electronic nicotine delivery system Electronic cigarettes Substance use disorder treatment |
| url | http://www.sciencedirect.com/science/article/pii/S2352853222000608 |
| work_keys_str_mv | AT carmenlmasson lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment AT noahrgubner lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment AT nealbenowitz lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment AT sindhushreehosakote lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment AT thaole lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment AT josephrguydish lifetimeuseofnonnicotinedrugsinelectroniccigarettedevicesamongasampleofindividualsinsubstanceusedisordertreatment |